CanadaTeva-Topilene Ointment 0.05% (betamethasone dipropionate, DIN 00849669), lot 689123, is affected; verify the product and lot number on your packaging. It was recalled because the assay is potentially out of specification in the affected lot during its shelf life. Verify if your product is affected, consult your healthcare provider before stopping use or for health concerns, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Teva Canada Limited., 30 Novopharm Court,, Toronto, ON,, M1B 2K9.
How to identify it
Brand: Teva-Topilene Ointment 0.05%; Product Name: Teva-Topilene Ointment 0.05%; Market Authorization: DIN 00849669; Dosage Form: Ointment; Strength: Betamethasone dipropionate, 0.05%; Lot: 689123
The hazard
The assay is potentially out of specification in the affected lot during its shelf life.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)